Literature DB >> 21084979

Cutaneous features in 17q21.31 deletion syndrome: a differential diagnosis for cardio-facio-cutaneous syndrome.

Emma Burkitt Wright1, Dian Donnai, Diana Johnson, Jill Clayton-Smith.   

Abstract

Microdeletion of 17q21.31 causes a recurrent recognizable dysmorphic syndrome. A further four patients with 17q21.31 microdeletions are reported here in whom an earlier diagnosis of cardio-facio-cutaneous syndrome was suggested. These patients have significant similarities of facial gestalt to earlier reported 17q21.31 microdeletion patients, but a striking feature that has not been emphasized previously is the large number of naevi and other pigmentary skin abnormalities that may be present. These features, together with a coarse facial appearance, relative macrocephaly and significant learning disabilities, were what had led to the earlier diagnostic suggestion of cardio-facio-cutaneous syndrome in each of these four cases.

Entities:  

Mesh:

Year:  2011        PMID: 21084979      PMCID: PMC3000393          DOI: 10.1097/MCD.0b013e32833e8f1e

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.884


  9 in total

Review 1.  RAS-MAPK pathway disorders: important causes of congenital heart disease, feeding difficulties, developmental delay and short stature.

Authors:  Emma M M Burkitt Wright; Bronwyn Kerr
Journal:  Arch Dis Child       Date:  2010-04-06       Impact factor: 3.791

2.  Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome.

Authors:  T Y Tan; S Aftimos; L Worgan; R Susman; M Wilson; S Ghedia; E P Kirk; D Love; A Ronan; A Darmanian; A Slavotinek; J Hogue; J B Moeschler; J Ozmore; R Widmer; Damien Bruno; R Savarirayan; G Peters
Journal:  J Med Genet       Date:  2009-05-15       Impact factor: 6.318

3.  Neurofibromatosis: emerging phenotypes, mechanisms and management.

Authors:  Susan Huson
Journal:  Clin Med (Lond)       Date:  2008-12       Impact factor: 2.659

4.  A new syndrome: mental subnormality and nasal papillomata.

Authors:  J M Costello
Journal:  Aust Paediatr J       Date:  1977-06

5.  A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism.

Authors:  David A Koolen; Lisenka E L M Vissers; Rolph Pfundt; Nicole de Leeuw; Samantha J L Knight; Regina Regan; R Frank Kooy; Edwin Reyniers; Corrado Romano; Marco Fichera; Albert Schinzel; Alessandra Baumer; Britt-Marie Anderlid; Jacqueline Schoumans; Nine V Knoers; Ad Geurts van Kessel; Erik A Sistermans; Joris A Veltman; Han G Brunner; Bert B A de Vries
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

6.  New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement--the CFC syndrome.

Authors:  J F Reynolds; G Neri; J P Herrmann; B Blumberg; J G Coldwell; P V Miles; J M Opitz
Journal:  Am J Med Genet       Date:  1986-11

7.  Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations.

Authors:  C M Armour; J E Allanson
Journal:  J Med Genet       Date:  2007-11-26       Impact factor: 6.318

8.  Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability.

Authors:  Charles Shaw-Smith; Alan M Pittman; Lionel Willatt; Howard Martin; Lisa Rickman; Susan Gribble; Rebecca Curley; Sally Cumming; Carolyn Dunn; Dimitrios Kalaitzopoulos; Keith Porter; Elena Prigmore; Ana C V Krepischi-Santos; Monica C Varela; Celia P Koiffmann; Andrew J Lees; Carla Rosenberg; Helen V Firth; Rohan de Silva; Nigel P Carter
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

9.  Clinical and molecular delineation of the 17q21.31 microdeletion syndrome.

Authors:  D A Koolen; A J Sharp; J A Hurst; H V Firth; S J L Knight; A Goldenberg; P Saugier-Veber; R Pfundt; L E L M Vissers; A Destrée; B Grisart; L Rooms; N Van der Aa; M Field; A Hackett; K Bell; M J M Nowaczyk; G M S Mancini; P J Poddighe; C E Schwartz; E Rossi; M De Gregori; L L Antonacci-Fulton; M D McLellan; J M Garrett; M A Wiechert; T L Miner; S Crosby; R Ciccone; L Willatt; A Rauch; M Zenker; S Aradhya; M A Manning; T M Strom; J Wagenstaller; A C Krepischi-Santos; A M Vianna-Morgante; C Rosenberg; S M Price; H Stewart; C Shaw-Smith; H G Brunner; A O M Wilkie; J A Veltman; O Zuffardi; E E Eichler; B B A de Vries
Journal:  J Med Genet       Date:  2008-07-15       Impact factor: 6.318

  9 in total
  4 in total

1.  The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant.

Authors:  David A Koolen; Rolph Pfundt; Katrin Linda; Gea Beunders; Hermine E Veenstra-Knol; Jessie H Conta; Ana Maria Fortuna; Gabriele Gillessen-Kaesbach; Sarah Dugan; Sara Halbach; Omar A Abdul-Rahman; Heather M Winesett; Wendy K Chung; Marguerite Dalton; Petia S Dimova; Teresa Mattina; Katrina Prescott; Hui Z Zhang; Howard M Saal; Jayne Y Hehir-Kwa; Marjolein H Willemsen; Charlotte W Ockeloen; Marjolijn C Jongmans; Nathalie Van der Aa; Pinella Failla; Concetta Barone; Emanuela Avola; Alice S Brooks; Sarina G Kant; Erica H Gerkes; Helen V Firth; Katrin Õunap; Lynne M Bird; Diane Masser-Frye; Jennifer R Friedman; Modupe A Sokunbi; Abhijit Dixit; Miranda Splitt; Mary K Kukolich; Julie McGaughran; Bradley P Coe; Jesús Flórez; Nael Nadif Kasri; Han G Brunner; Elizabeth M Thompson; Jozef Gecz; Corrado Romano; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

2.  Complex phenotype associated with 17q21.31 microdeletion.

Authors:  H Dornelles-Wawruk; A Pic-Taylor; C Rosenberg; A C V Krepischi; H P N Safatle; I Ferrari; J F Mazzeu
Journal:  Mol Syndromol       Date:  2013-08-21

3.  Prenatal ultrasound findings in Koolen-de Vries foetuses: Central nervous system anomalies are frequent markers of this syndrome.

Authors:  Fe Amalia García-Santiago; Cristina Martínez-Payo; Elena Mansilla; Fernando Santos-Simarro; Miguel Ruiz de Azua Ballesteros; María Ángeles Mori; Eugenia Antolín Alvarado; Yolanda Nieto; Isabel Vallcorba; Jair Tenorio; Julián Nevado; Pablo Lapunzina
Journal:  Mol Genet Genomic Med       Date:  2021-03-18       Impact factor: 2.183

4.  KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome.

Authors:  María Moreno-Igoa; Blanca Hernández-Charro; Amaya Bengoa-Alonso; Aranzazu Pérez-Juana-del-Casal; Carlos Romero-Ibarra; Beatriz Nieva-Echebarria; María Antonia Ramos-Arroyo
Journal:  BMC Med Genet       Date:  2015-08-22       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.